Sale!

Goodpasture Syndrome Panel Test

Original price was: $162.Current price is: $112.

-31%

The Goodpasture Syndrome Panel is a specialized diagnostic test that detects autoimmune antibodies attacking the kidneys and lungs. This comprehensive panel measures Glomerular Basement Membrane Antibody and ANCA-PR3/c-ANCA to identify Goodpasture syndrome, a rare but serious autoimmune condition. Patients experiencing symptoms like coughing up blood, shortness of breath, fatigue, or kidney problems should consider this test for early diagnosis. The panel provides crucial information for nephrologists and chest physicians to develop targeted treatment plans. With results available next day and no special preparation required, this $112 USD test offers peace of mind and timely intervention for potentially life-threatening conditions affecting both renal and respiratory systems.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Goodpasture Syndrome Panel Test

Understanding Goodpasture Syndrome and Diagnostic Testing

Goodpasture Syndrome represents a rare autoimmune disorder characterized by the simultaneous attack on both kidney glomeruli and lung alveoli by specific antibodies. This condition, while uncommon, can progress rapidly and lead to severe kidney failure and respiratory complications if left undiagnosed. The Goodpasture Syndrome Panel serves as a critical diagnostic tool that enables healthcare providers to identify this autoimmune condition early, facilitating timely intervention and potentially life-saving treatment.

What Does the Goodpasture Syndrome Panel Measure?

This comprehensive immunopathology panel evaluates two crucial antibody markers:

  • Glomerular Basement Membrane Antibody (Anti-GBM): This antibody specifically targets the collagen in the basement membranes of kidney glomeruli and lung alveoli, causing inflammation and tissue damage.
  • ANCA-PR3 / c-ANCA: Antineutrophil cytoplasmic antibodies, particularly proteinase-3 (PR3) and cytoplasmic pattern (c-ANCA), help differentiate Goodpasture syndrome from other vasculitic conditions with similar presentations.

Who Should Consider This Diagnostic Test?

Recognizing the Warning Signs

Individuals experiencing the following symptoms should discuss testing with their healthcare provider:

  • Unexplained coughing up of blood (hemoptysis)
  • Progressive shortness of breath or difficulty breathing
  • Fatigue, weakness, and general malaise
  • Blood in urine (hematuria) or foamy urine
  • Swelling in legs, ankles, or around the eyes
  • High blood pressure that develops suddenly
  • Decreased urine output or kidney function abnormalities
  • Unexplained weight loss and fever

Clinical Benefits of Early Detection

Why Timely Testing Matters

Early diagnosis through the Goodpasture Syndrome Panel offers multiple advantages:

  • Prevention of Permanent Organ Damage: Early intervention can prevent irreversible kidney and lung damage
  • Targeted Treatment Planning: Results guide nephrologists and chest physicians in developing precise treatment strategies
  • Improved Prognosis: Timely diagnosis significantly improves long-term outcomes and quality of life
  • Differential Diagnosis: Helps distinguish Goodpasture syndrome from other autoimmune conditions with similar symptoms
  • Monitoring Treatment Response: Serial testing can track antibody levels and treatment effectiveness

Understanding Your Test Results

Interpreting the Laboratory Findings

Your test results will be carefully analyzed by our specialized immunopathology team:

  • Positive Anti-GBM Antibody: Indicates active Goodpasture syndrome requiring immediate medical intervention
  • Positive ANCA-PR3/c-ANCA: May suggest overlapping vasculitic conditions or help confirm the diagnosis
  • Negative Results: Typically rule out Goodpasture syndrome, though clinical correlation remains essential
  • Borderline Values: May require repeat testing or additional diagnostic evaluation

All results should be discussed with your healthcare provider, who will consider your complete clinical picture, symptoms, and other laboratory findings to provide comprehensive medical guidance.

Test Information and Pricing

Test Component Details
Test Name Goodpasture Syndrome Panel
Discount Price $112 USD
Regular Price $162 USD
Turnaround Time Sample Monday/Wednesday by 9 AM; Report Next Day
Sample Type 3 ml (1.5 mL min.) serum from 1 SST
Shipping Requirements Ship refrigerated or frozen
Test Methodology Enzyme Immunoassay, IFA
Specialties Involved Nephrologist, Chest Physician
Department Immunopathology

Nationwide Testing Accessibility

We maintain comprehensive testing facilities across the United States, ensuring convenient access to this critical diagnostic service. Our network includes specialized collection centers in:

  • New York City and surrounding metropolitan areas
  • Los Angeles and Southern California regions
  • Chicago and Illinois healthcare facilities
  • Houston, Dallas, and Texas medical centers
  • Phoenix and Arizona diagnostic locations
  • Philadelphia and Pennsylvania testing sites
  • San Antonio, San Diego, and additional major cities

Take Action for Your Health Today

Don’t wait for symptoms to progress. Early detection of Goodpasture syndrome can make a significant difference in treatment outcomes and long-term health. Our streamlined testing process requires no special preparation, and our rapid turnaround time ensures you receive results when they matter most.

Ready to schedule your Goodpasture Syndrome Panel? Contact our dedicated healthcare team today to book your test or discuss your testing needs. Call or WhatsApp us at +1(267) 388-9828 to speak with our medical professionals and take the first step toward comprehensive autoimmune disorder diagnosis and management.

Our experienced immunopathology specialists are available to answer your questions, explain the testing process, and help you understand how this panel can contribute to your overall health assessment. Trust in our commitment to accurate diagnostics and patient-centered care.